indirubin has been researched along with 7-bromoindirubin-3'-oxime in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bettayeb, K; Ferandin, Y; Kritsanida, M; Lozach, O; Magiatis, P; Meijer, L; Polychronopoulos, P; Skaltsounis, AL | 1 |
| Evdokimov, NM; Kornienko, A; Magedov, IV; McBrayer, D | 1 |
| Gaboriaud-Kolar, N; Gerolymatos, P; Horne, DA; Jove, R; Mikros, E; Myrianthopoulos, V; Nam, S; Skaltsounis, AL; Vougogiannopoulou, K | 1 |
| Bai, G; Chen, Y; Wang, H; Wang, J; Wang, Z; Wei, C; Xu, Y; Yao, Q; Zhang, L | 1 |
| Ferandin, Y; Magiatis, P; Meijer, L; Mikros, E; Myrianthopoulos, V; Skaltsounis, AL | 1 |
| Begum, J; Bischler, N; Hayes, JM; Leonidas, DD; Moffatt, C; Oikonomakos, NG; Sarrou, J; Skaltsounis, AL; Skamnaki, VT | 1 |
1 review(s) available for indirubin and 7-bromoindirubin-3'-oxime
| Article | Year |
|---|---|
Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship.
Topics: Antineoplastic Agents; Cell Survival; Chemistry, Pharmaceutical; Drugs, Chinese Herbal; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oximes; Structure-Activity Relationship | 2021 |
5 other study(ies) available for indirubin and 7-bromoindirubin-3'-oxime
| Article | Year |
|---|---|
3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.
Topics: Antineoplastic Agents; Bromine; Cell Death; Cell Line, Tumor; Chlorine; Drug Screening Assays, Antitumor; Fluorine; Humans; Indoles; Iodine; Models, Molecular; Stereoisomerism; Structure-Activity Relationship | 2006 |
Isatin derivatives with activity against apoptosis-resistant cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isatin; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2016 |
Natural-Based Indirubins Display Potent Cytotoxicity toward Wild-Type and T315I-Resistant Leukemia Cell Lines.
Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; CSK Tyrosine-Protein Kinase; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases | 2016 |
An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins.
Topics: Amino Acid Sequence; Aurora Kinases; Binding Sites; Indoles; Models, Molecular; Molecular Sequence Data; Oximes; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quantitative Structure-Activity Relationship; Sequence Homology, Amino Acid; Thermodynamics | 2007 |
An evaluation of indirubin analogues as phosphorylase kinase inhibitors.
Topics: Amino Acid Motifs; Binding Sites; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; High-Throughput Screening Assays; Humans; Hypoglycemic Agents; Indoles; Ligands; Molecular Docking Simulation; Molecular Sequence Data; Oximes; Phosphorylase Kinase; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Secondary; Protein Structure, Tertiary; Structure-Activity Relationship; Thermodynamics; User-Computer Interface | 2015 |